Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364410
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-04-12
Brief Title:
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan DS-8201a and Azenosertib ZN-c3 in Patients With Stomach or Other Solid Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Clinical Stage III Gastric Cancer AJCC v8 |
| Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Clinical Stage IV Gastric Cancer AJCC v8 |
| Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 |
| Locally Advanced Gastric Carcinoma |
| Locally Advanced Gastroesophageal Junction Adenocarcinoma |
| Locally Advanced Malignant Solid Neoplasm |
| Metastatic Gastric Carcinoma |
| Metastatic Gastroesophageal Junction Adenocarcinoma |
| Metastatic Malignant Solid Neoplasm |
| Unresectable Gastric Carcinoma |
| Unresectable Gastroesophageal Junction Adenocarcinoma |
| Unresectable Malignant Solid Neoplasm |
Keywords: